We serve Chemical Name:N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine CAS:36770-74-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine
CAS.NO:36770-74-8
Synonyms:N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine
Molecular Formula:C14H22ClNO2
Molecular Weight:271.78300
HS Code:2922299090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:361.8ºC at 760mmHg
Density:1.066g/cm3
Index of Refraction:1.51
PSA:21.70000
Exact Mass:271.13400
LogP:2.80700
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine Use and application,N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine technical grade,usp/ep/jp grade.
Related News: As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics. N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine manufacturer The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine supplier Safety concerns about the J&J vaccine paired with flagging U.S. demand for vaccinations in general have slowed rollout of the one-shot vaccine to a crawl. Close to half of the 21 million doses produced for the United States sit unused. N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine vendor The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. N-Methyl-N-(3-chloropropyl)-3,4-dimethoxyphenethylamine factory As part of the deal, CROS NT CEO Paolo Morelli becomes Alira’s executive vice president of biometrics.
